U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 310

1.
CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
Erik Wennerberg, Veronika Kremer, Richard Childs, Andreas Lundqvist
Cancer Immunol Immunother. 2015 Feb; 64(2): 225–235. Published online 2014 Oct 26. doi: 10.1007/s00262-014-1629-5
PMCID:
PMC11028951
AbstractArticlePDF–382K
2.
Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity
Luna Dillemans, Karen Yu, Alexandra De Zutter, Sam Noppen, Mieke Gouwy, Nele Berghmans, Lisa Verhallen, Mirre De Bondt, Lotte Vanbrabant, Stef Brusselmans, Erik Martens, Dominique Schols, Patrick Verschueren, Mette M. Rosenkilde, Pedro Elias Marques, Sofie Struyf, Paul Proost
Cell Commun Signal. 2024; 22: 94. Published online 2024 Feb 2. doi: 10.1186/s12964-023-01453-1
PMCID:
PMC10835923
AbstractArticlePDF–5.7M
3.
CXCL10 Expression in Human Colorectal Cancer Tissue and its Correlation With Serum Levels of CXCL10
LIANBO LI, KOSUKE KANEMITSU, KOJI OHNISHI, RIN YAMADA, HIROMU YANO, YUKIO FUJIWARA, YUJI MIYAMOTO, YOSHIKI MIKAMI, TAIZO HIBI, HIDEO BABA, YOSHIHIRO KOMOHARA
Cancer Genomics Proteomics. 2024 Jan-Feb; 21(1): 54–64. Published online 2024 Jan 3. doi: 10.21873/cgp.20429
PMCID:
PMC10756351
AbstractArticlePDF–9.1M
4.
High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studies
Yehya Al-Adwi, Isabella Maria Atzeni, Berber Doornbos-van der Meer, Marcel John van der Leij, Rita Delphine Maiko Varkevisser, Bart-Jan Kroesen, Alja Stel, Wim Timens, Christiaan Tji Gan, Harry van Goor, Johanna Westra, Douwe Johannes Mulder
eBioMedicine. 2023 Dec; 98: 104883. Published online 2023 Nov 22. doi: 10.1016/j.ebiom.2023.104883
PMCID:
PMC10708993
AbstractArticlePDF–1.7M
5.
CXCL10 Is Associated with Increased Cerebrospinal Fluid Immune Cell Infiltration and Disease Duration in Multiple Sclerosis
Stephanie N. Blandford, Neva J. Fudge, Craig S. Moore
Biomolecules. 2023 Aug; 13(8): 1204. Published online 2023 Aug 1. doi: 10.3390/biom13081204
PMCID:
PMC10452246
AbstractArticlePDF–9.1M
6.
Disparate Regions of the Human Chemokine CXCL10 Exhibit Broad-Spectrum Antimicrobial Activity against Biodefense and Antibiotic-Resistant Bacterial Pathogens
Matthew A. Crawford, Amanda E. Ward, Vincent Gray, Peter Bailer, Debra J. Fisher, Ewa Kubicka, Zixian Cui, Qinmo Luo, Mary C. Gray, Alison K. Criss, Lawrence G. Lum, Lukas K. Tamm, Rachel A. Letteri, Molly A. Hughes
ACS Infect Dis. 2023 Jan 13; 9(1): 122–139. Published online 2022 Dec 7. doi: 10.1021/acsinfecdis.2c00456
PMCID:
PMC9841529
AbstractArticlePDF–7.8M
7.
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia
Charilaos Samaras, Evdoxia Kyriazopoulou, Garyfallia Poulakou, Eran Reiner, Maria Kosmidou, Ioanna Karanika, Vasileios Petrakis, George Adamis, Nikolaos K. Gatselis, Archontoula Fragkou, Aggeliki Rapti, Eleonora Taddei, Ioannis Kalomenidis, George Chrysos, Giulia Bertoli, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Evangelos Kostis, Lorenzo Dagna, Sofia Koukidou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Christina Trakatelli, George Tsoukalas, Carlo Selmi, Michael Samarkos, Athina Pyrpasopoulou, Aikaterini Masgala, Emmanouil Antonakis, Aikaterini Argyraki, Karolina Akinosoglou, Styliani Sympardi, Periklis Panagopoulos, Haralampos Milionis, Simeon Metallidis, Konstantinos N. Syrigos, Alon Angel, George N. Dalekos, Mihai G. Netea, Evangelos J. Giamarellos-Bourboulis
Cytokine. 2023 Feb; 162: 156111. Published online 2022 Dec 14. doi: 10.1016/j.cyto.2022.156111
PMCID:
PMC9747699
AbstractArticlePDF–3.3M
8.
CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma
Jingya Zhang, Dong Dong, Qian Wei, Li Ren
BMC Cancer. 2022; 22: 1052. Published online 2022 Oct 8. doi: 10.1186/s12885-022-10142-0
PMCID:
PMC9547472
AbstractArticlePDF–1.6M
9.
IP-10 and complement activation as friend or foe in COVID-19
Saowalak Bunprakob, Pasin Hemachudha, Chanida Ruchisrisarod, Thirawat Supharatpariyakorn, Thiravat Hemachudha
Int J Immunopathol Pharmacol. 2022 Jan-Dec; 36: 03946320221096202. Published online 2022 May 9. doi: 10.1177/03946320221096202
PMCID:
PMC9092585
AbstractArticlePDF–954K
10.
What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection?
Monika Gudowska-Sawczuk, Barbara Mroczko
Int J Mol Sci. 2022 Apr; 23(7): 3673. Published online 2022 Mar 27. doi: 10.3390/ijms23073673
PMCID:
PMC8998241
AbstractArticlePDF–975K
11.
Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10
Weiyuan Li, Ji-Ao Ma, Xun Sheng, Chunjie Xiao
World J Surg Oncol. 2021; 19: 329. Published online 2021 Nov 18. doi: 10.1186/s12957-021-02440-x
PMCID:
PMC8600898
AbstractArticlePDF–11M
12.
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study
Nicola I. Lorè, Rebecca De Lorenzo, Paola M. V. Rancoita, Federica Cugnata, Alessandra Agresti, Francesco Benedetti, Marco E. Bianchi, Chiara Bonini, Annalisa Capobianco, Caterina Conte, Angelo Corti, Roberto Furlan, Paola Mantegani, Norma Maugeri, Clara Sciorati, Fabio Saliu, Laura Silvestri, Cristina Tresoldi, Bio Angels for COVID-BioB Study Group, Fabio Ciceri, Patrizia Rovere-Querini, Clelia Di Serio, Daniela M. Cirillo, Angelo A. Manfredi
Mol Med. 2021; 27: 129. Published online 2021 Oct 18. doi: 10.1186/s10020-021-00390-4
PMCID:
PMC8521494
AbstractArticlePDF–2.1M
13.
CXCL10 and its related key genes as potential biomarkers for psoriasis: Evidence from bioinformatics and real-time quantitative polymerase chain reaction
Ailing Zou, Qichao Jian
Medicine (Baltimore) 2021 Sep 24; 100(38): e27365. Published online 2021 Sep 24. doi: 10.1097/MD.0000000000027365
PMCID:
PMC8462640
AbstractArticlePDF–1.6M
14.
Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast
Milim Kim, Hye Yeon Choi, Ji Won Woo, Yul Ri Chung, So Yeon Park
Sci Rep. 2021; 11: 18007. Published online 2021 Sep 9. doi: 10.1038/s41598-021-97390-5
PMCID:
PMC8429587
AbstractArticlePDF–5.8M
15.
Serum CXCL10/IP-10 may be a potential biomarker for severe Mycoplasma pneumoniae pneumonia in children
Mengyao Li, Ying Chen, Huihan Li, Dehua Yang, Yunlian Zhou, Zhimin Chen, Yuanyuan Zhang
BMC Infect Dis. 2021; 21: 909. Published online 2021 Sep 4. doi: 10.1186/s12879-021-06632-4
PMCID:
PMC8418284
AbstractArticlePDF–1.3M
16.
Malaria parasites both repress host CXCL10 and use it as a cue for growth acceleration
Yifat Ofir-Birin, Hila Ben Ami Pilo, Abel Cruz Camacho, Ariel Rudik, Anna Rivkin, Or-Yam Revach, Netta Nir, Tal Block Tamin, Paula Abou Karam, Edo Kiper, Yoav Peleg, Reinat Nevo, Aryeh Solomon, Tal Havkin-Solomon, Alicia Rojas, Ron Rotkopf, Ziv Porat, Dror Avni, Eli Schwartz, Thomas Zillinger, Gunther Hartmann, Antonella Di Pizio, Neils Ben Quashie, Rivka Dikstein, Motti Gerlic, Ana Claudia Torrecilhas, Carmit Levy, Esther N. M. Nolte-‘t Hoen, Andrew G. Bowie, Neta Regev-Rudzki
Nat Commun. 2021; 12: 4851. Published online 2021 Aug 11. doi: 10.1038/s41467-021-24997-7
PMCID:
PMC8357946
AbstractArticlePDF–1.3M
17.
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes
Laura Ardighieri, Francesco Missale, Mattia Bugatti, Luisa Benerini Gatta, Irene Pezzali, Matilde Monti, Stefano Gottardi, Laura Zanotti, Eliana Bignotti, Antonella Ravaggi, Germana Tognon, Franco Odicino, Stefano Calza, Yoann Missolo-Koussou, Carola Hermine Ries, Julie Helft, William Vermi
Front Immunol. 2021; 12: 690201. Published online 2021 Jun 18. doi: 10.3389/fimmu.2021.690201
PMCID:
PMC8253056
AbstractArticlePDF–16M
18.
CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors
Zhiwen Shi, Jianfeng Shen, Junjun Qiu, Qingguo Zhao, Keqin Hua, Hongyan Wang
Theranostics. 2021; 11(15): 7175–7187. Published online 2021 May 24. doi: 10.7150/thno.59056
PMCID:
PMC8210593
AbstractArticlePDF–3.9M
19.
Serum IP-10 and IL-7 levels are associated with disease severity of coronavirus disease 2019
Guo-Lin Wang, Hui-Xia Gao, Yu-Ling Wang, Xiao Wei, Yu-Zhen Liu, Jian-Hua Lu, Li Li, Hai-Bin Wang, Lei Zhao, Yan-Xiao Rong, Lin Yao, Li-Juan Duan, Benjamin D. Anderson, Mai-Juan Ma, Er-Hei Dai, Xiang-Na Zhao
Cytokine. 2021 Jun; 142: 155500. Published online 2021 Mar 19. doi: 10.1016/j.cyto.2021.155500
PMCID:
PMC7973056
AbstractArticlePDF–620K
20.
Elevation of cervical CXCL10 levels is associated with HIV-1 acquisition in pregnant and postpartum women
Michelle C. SABO, Dara A. LEHMAN, Jillian C. PINTYE, Bingjie WANG, Alison L. DRAKE, John KINUTHIA, Lusi OSBORN, Daniel MATEMO, Barbra A. RICHARDSON, Julie OVERBAUGH, Grace JOHN-STEWART, Susan M. GRAHAM
AIDS. Author manuscript; available in PMC 2021 Oct 1.
Published in final edited form as: AIDS. 2020 Oct 1; 34(12): 1725–1733. doi: 10.1097/QAD.0000000000002613
PMCID:
PMC7964249
AbstractArticlePDF–753K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center